Skip to content

Drug interactions

Posaconazole + Quizartinib

Severity: Major

Posaconazole and Quizartinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Posaconazole increases quizartinib exposure, raising the risk of QT prolongation and torsades de pointes. Both drugs also prolong QT directly.

What this interaction means in plain words

Posaconazole and Quizartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Posaconazole belongs to Anti Fungals; Quizartinib belongs to Oncology.

Evidence level: High

Why it happens

Strong CYP3A4 inhibition reduces quizartinib clearance, with additive QT effects.

What to do

Reduce the quizartinib dose per labeling for strong CYP3A inhibitors, or interrupt it if already at the lowest dose. Monitor ECG and electrolytes, and restore the prior dose after stopping posaconazole.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Posaconazole and Quizartinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Posaconazole with Quizartinib?

MediHelp rates the interaction as major. Posaconazole and Quizartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Posaconazole increases quizartinib exposure, raising the risk of QT prolongation and torsades de pointes. Both drugs also prolong QT directly.

How serious is the interaction between Posaconazole and Quizartinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce the quizartinib dose per labeling for strong CYP3A inhibitors, or interrupt it if already at the lowest dose. Monitor ECG and electrolytes, and restore the prior dose after stopping posaconazole.

What other medicines interact with Posaconazole?

MediHelp also lists interactions of Posaconazole with, for example, Artemether, Avanafil, Cobimetinib. The full list is on the Posaconazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in